Medical Care
Global Renal Anemia Therapeutics Market Research Report 2024
- Jan 20, 24
- ID: 12810
- Pages: 89
- Figures: 171
- Views: 45
The global Renal Anemia Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Renal Anemia Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Anemia Therapeutics.
Report Scope
The Renal Anemia Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Renal Anemia Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Renal Anemia Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
BIOCAD
CCM Duopharma Biotech Bhd.
Chong Kun Dang Pharmaceutical Corp.
Daiichi Sankyo Company, Limited
Dong-A Socio Group
Dr. Reddy's Laboratories Limited
Eli Lilly and Company
FibroGen, Inc.
GlaxoSmithKline Plc
Intas Pharmaceuticals Ltd.
Japan Tobacco Inc.
JCR Pharmaceuticals Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Segment by Type
DS-1093
EPO-018B
FG-2216
JTZ-951
MDGN-201
MMP-0101
Others
Segment by Application
Hospital
Research Center
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Renal Anemia Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Renal Anemia Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Anemia Therapeutics.
Report Scope
The Renal Anemia Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Renal Anemia Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Renal Anemia Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
BIOCAD
CCM Duopharma Biotech Bhd.
Chong Kun Dang Pharmaceutical Corp.
Daiichi Sankyo Company, Limited
Dong-A Socio Group
Dr. Reddy's Laboratories Limited
Eli Lilly and Company
FibroGen, Inc.
GlaxoSmithKline Plc
Intas Pharmaceuticals Ltd.
Japan Tobacco Inc.
JCR Pharmaceuticals Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Segment by Type
DS-1093
EPO-018B
FG-2216
JTZ-951
MDGN-201
MMP-0101
Others
Segment by Application
Hospital
Research Center
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Renal Anemia Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Anemia Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DS-1093
1.2.3 EPO-018B
1.2.4 FG-2216
1.2.5 JTZ-951
1.2.6 MDGN-201
1.2.7 MMP-0101
1.2.8 Others
1.3 Market by Application
1.3.1 Global Renal Anemia Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Research Center
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Anemia Therapeutics Market Perspective (2019-2030)
2.2 Renal Anemia Therapeutics Growth Trends by Region
2.2.1 Global Renal Anemia Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Renal Anemia Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Renal Anemia Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Renal Anemia Therapeutics Market Dynamics
2.3.1 Renal Anemia Therapeutics Industry Trends
2.3.2 Renal Anemia Therapeutics Market Drivers
2.3.3 Renal Anemia Therapeutics Market Challenges
2.3.4 Renal Anemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Anemia Therapeutics Players by Revenue
3.1.1 Global Top Renal Anemia Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Renal Anemia Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Renal Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Renal Anemia Therapeutics Revenue
3.4 Global Renal Anemia Therapeutics Market Concentration Ratio
3.4.1 Global Renal Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Anemia Therapeutics Revenue in 2023
3.5 Renal Anemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Renal Anemia Therapeutics Product Solution and Service
3.7 Date of Enter into Renal Anemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Anemia Therapeutics Breakdown Data by Type
4.1 Global Renal Anemia Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Renal Anemia Therapeutics Forecasted Market Size by Type (2025-2030)
5 Renal Anemia Therapeutics Breakdown Data by Application
5.1 Global Renal Anemia Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Renal Anemia Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Renal Anemia Therapeutics Market Size (2019-2030)
6.2 North America Renal Anemia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Renal Anemia Therapeutics Market Size by Country (2019-2024)
6.4 North America Renal Anemia Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Renal Anemia Therapeutics Market Size (2019-2030)
7.2 Europe Renal Anemia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Renal Anemia Therapeutics Market Size by Country (2019-2024)
7.4 Europe Renal Anemia Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Renal Anemia Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Renal Anemia Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Renal Anemia Therapeutics Market Size (2019-2030)
9.2 Latin America Renal Anemia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Renal Anemia Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Renal Anemia Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Anemia Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Renal Anemia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Renal Anemia Therapeutics Introduction
11.1.4 Bayer AG Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.1.5 Bayer AG Recent Development
11.2 BIOCAD
11.2.1 BIOCAD Company Detail
11.2.2 BIOCAD Business Overview
11.2.3 BIOCAD Renal Anemia Therapeutics Introduction
11.2.4 BIOCAD Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.2.5 BIOCAD Recent Development
11.3 CCM Duopharma Biotech Bhd.
11.3.1 CCM Duopharma Biotech Bhd. Company Detail
11.3.2 CCM Duopharma Biotech Bhd. Business Overview
11.3.3 CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Introduction
11.3.4 CCM Duopharma Biotech Bhd. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.3.5 CCM Duopharma Biotech Bhd. Recent Development
11.4 Chong Kun Dang Pharmaceutical Corp.
11.4.1 Chong Kun Dang Pharmaceutical Corp. Company Detail
11.4.2 Chong Kun Dang Pharmaceutical Corp. Business Overview
11.4.3 Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Introduction
11.4.4 Chong Kun Dang Pharmaceutical Corp. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.4.5 Chong Kun Dang Pharmaceutical Corp. Recent Development
11.5 Daiichi Sankyo Company, Limited
11.5.1 Daiichi Sankyo Company, Limited Company Detail
11.5.2 Daiichi Sankyo Company, Limited Business Overview
11.5.3 Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Introduction
11.5.4 Daiichi Sankyo Company, Limited Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.5.5 Daiichi Sankyo Company, Limited Recent Development
11.6 Dong-A Socio Group
11.6.1 Dong-A Socio Group Company Detail
11.6.2 Dong-A Socio Group Business Overview
11.6.3 Dong-A Socio Group Renal Anemia Therapeutics Introduction
11.6.4 Dong-A Socio Group Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.6.5 Dong-A Socio Group Recent Development
11.7 Dr. Reddy's Laboratories Limited
11.7.1 Dr. Reddy's Laboratories Limited Company Detail
11.7.2 Dr. Reddy's Laboratories Limited Business Overview
11.7.3 Dr. Reddy's Laboratories Limited Renal Anemia Therapeutics Introduction
11.7.4 Dr. Reddy's Laboratories Limited Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.7.5 Dr. Reddy's Laboratories Limited Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Detail
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Renal Anemia Therapeutics Introduction
11.8.4 Eli Lilly and Company Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.8.5 Eli Lilly and Company Recent Development
11.9 FibroGen, Inc.
11.9.1 FibroGen, Inc. Company Detail
11.9.2 FibroGen, Inc. Business Overview
11.9.3 FibroGen, Inc. Renal Anemia Therapeutics Introduction
11.9.4 FibroGen, Inc. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.9.5 FibroGen, Inc. Recent Development
11.10 GlaxoSmithKline Plc
11.10.1 GlaxoSmithKline Plc Company Detail
11.10.2 GlaxoSmithKline Plc Business Overview
11.10.3 GlaxoSmithKline Plc Renal Anemia Therapeutics Introduction
11.10.4 GlaxoSmithKline Plc Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.10.5 GlaxoSmithKline Plc Recent Development
11.11 Intas Pharmaceuticals Ltd.
11.11.1 Intas Pharmaceuticals Ltd. Company Detail
11.11.2 Intas Pharmaceuticals Ltd. Business Overview
11.11.3 Intas Pharmaceuticals Ltd. Renal Anemia Therapeutics Introduction
11.11.4 Intas Pharmaceuticals Ltd. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.11.5 Intas Pharmaceuticals Ltd. Recent Development
11.12 Japan Tobacco Inc.
11.12.1 Japan Tobacco Inc. Company Detail
11.12.2 Japan Tobacco Inc. Business Overview
11.12.3 Japan Tobacco Inc. Renal Anemia Therapeutics Introduction
11.12.4 Japan Tobacco Inc. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.12.5 Japan Tobacco Inc. Recent Development
11.13 JCR Pharmaceuticals Co., Ltd.
11.13.1 JCR Pharmaceuticals Co., Ltd. Company Detail
11.13.2 JCR Pharmaceuticals Co., Ltd. Business Overview
11.13.3 JCR Pharmaceuticals Co., Ltd. Renal Anemia Therapeutics Introduction
11.13.4 JCR Pharmaceuticals Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.13.5 JCR Pharmaceuticals Co., Ltd. Recent Development
11.14 Jiangsu Hansoh Pharmaceutical Co., Ltd.
11.14.1 Jiangsu Hansoh Pharmaceutical Co., Ltd. Company Detail
11.14.2 Jiangsu Hansoh Pharmaceutical Co., Ltd. Business Overview
11.14.3 Jiangsu Hansoh Pharmaceutical Co., Ltd. Renal Anemia Therapeutics Introduction
11.14.4 Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.14.5 Jiangsu Hansoh Pharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Anemia Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DS-1093
1.2.3 EPO-018B
1.2.4 FG-2216
1.2.5 JTZ-951
1.2.6 MDGN-201
1.2.7 MMP-0101
1.2.8 Others
1.3 Market by Application
1.3.1 Global Renal Anemia Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Research Center
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Anemia Therapeutics Market Perspective (2019-2030)
2.2 Renal Anemia Therapeutics Growth Trends by Region
2.2.1 Global Renal Anemia Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Renal Anemia Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Renal Anemia Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Renal Anemia Therapeutics Market Dynamics
2.3.1 Renal Anemia Therapeutics Industry Trends
2.3.2 Renal Anemia Therapeutics Market Drivers
2.3.3 Renal Anemia Therapeutics Market Challenges
2.3.4 Renal Anemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Anemia Therapeutics Players by Revenue
3.1.1 Global Top Renal Anemia Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Renal Anemia Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Renal Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Renal Anemia Therapeutics Revenue
3.4 Global Renal Anemia Therapeutics Market Concentration Ratio
3.4.1 Global Renal Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Anemia Therapeutics Revenue in 2023
3.5 Renal Anemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Renal Anemia Therapeutics Product Solution and Service
3.7 Date of Enter into Renal Anemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Anemia Therapeutics Breakdown Data by Type
4.1 Global Renal Anemia Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Renal Anemia Therapeutics Forecasted Market Size by Type (2025-2030)
5 Renal Anemia Therapeutics Breakdown Data by Application
5.1 Global Renal Anemia Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Renal Anemia Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Renal Anemia Therapeutics Market Size (2019-2030)
6.2 North America Renal Anemia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Renal Anemia Therapeutics Market Size by Country (2019-2024)
6.4 North America Renal Anemia Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Renal Anemia Therapeutics Market Size (2019-2030)
7.2 Europe Renal Anemia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Renal Anemia Therapeutics Market Size by Country (2019-2024)
7.4 Europe Renal Anemia Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Renal Anemia Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Renal Anemia Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Renal Anemia Therapeutics Market Size (2019-2030)
9.2 Latin America Renal Anemia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Renal Anemia Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Renal Anemia Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Anemia Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Renal Anemia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Renal Anemia Therapeutics Introduction
11.1.4 Bayer AG Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.1.5 Bayer AG Recent Development
11.2 BIOCAD
11.2.1 BIOCAD Company Detail
11.2.2 BIOCAD Business Overview
11.2.3 BIOCAD Renal Anemia Therapeutics Introduction
11.2.4 BIOCAD Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.2.5 BIOCAD Recent Development
11.3 CCM Duopharma Biotech Bhd.
11.3.1 CCM Duopharma Biotech Bhd. Company Detail
11.3.2 CCM Duopharma Biotech Bhd. Business Overview
11.3.3 CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Introduction
11.3.4 CCM Duopharma Biotech Bhd. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.3.5 CCM Duopharma Biotech Bhd. Recent Development
11.4 Chong Kun Dang Pharmaceutical Corp.
11.4.1 Chong Kun Dang Pharmaceutical Corp. Company Detail
11.4.2 Chong Kun Dang Pharmaceutical Corp. Business Overview
11.4.3 Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Introduction
11.4.4 Chong Kun Dang Pharmaceutical Corp. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.4.5 Chong Kun Dang Pharmaceutical Corp. Recent Development
11.5 Daiichi Sankyo Company, Limited
11.5.1 Daiichi Sankyo Company, Limited Company Detail
11.5.2 Daiichi Sankyo Company, Limited Business Overview
11.5.3 Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Introduction
11.5.4 Daiichi Sankyo Company, Limited Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.5.5 Daiichi Sankyo Company, Limited Recent Development
11.6 Dong-A Socio Group
11.6.1 Dong-A Socio Group Company Detail
11.6.2 Dong-A Socio Group Business Overview
11.6.3 Dong-A Socio Group Renal Anemia Therapeutics Introduction
11.6.4 Dong-A Socio Group Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.6.5 Dong-A Socio Group Recent Development
11.7 Dr. Reddy's Laboratories Limited
11.7.1 Dr. Reddy's Laboratories Limited Company Detail
11.7.2 Dr. Reddy's Laboratories Limited Business Overview
11.7.3 Dr. Reddy's Laboratories Limited Renal Anemia Therapeutics Introduction
11.7.4 Dr. Reddy's Laboratories Limited Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.7.5 Dr. Reddy's Laboratories Limited Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Detail
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Renal Anemia Therapeutics Introduction
11.8.4 Eli Lilly and Company Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.8.5 Eli Lilly and Company Recent Development
11.9 FibroGen, Inc.
11.9.1 FibroGen, Inc. Company Detail
11.9.2 FibroGen, Inc. Business Overview
11.9.3 FibroGen, Inc. Renal Anemia Therapeutics Introduction
11.9.4 FibroGen, Inc. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.9.5 FibroGen, Inc. Recent Development
11.10 GlaxoSmithKline Plc
11.10.1 GlaxoSmithKline Plc Company Detail
11.10.2 GlaxoSmithKline Plc Business Overview
11.10.3 GlaxoSmithKline Plc Renal Anemia Therapeutics Introduction
11.10.4 GlaxoSmithKline Plc Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.10.5 GlaxoSmithKline Plc Recent Development
11.11 Intas Pharmaceuticals Ltd.
11.11.1 Intas Pharmaceuticals Ltd. Company Detail
11.11.2 Intas Pharmaceuticals Ltd. Business Overview
11.11.3 Intas Pharmaceuticals Ltd. Renal Anemia Therapeutics Introduction
11.11.4 Intas Pharmaceuticals Ltd. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.11.5 Intas Pharmaceuticals Ltd. Recent Development
11.12 Japan Tobacco Inc.
11.12.1 Japan Tobacco Inc. Company Detail
11.12.2 Japan Tobacco Inc. Business Overview
11.12.3 Japan Tobacco Inc. Renal Anemia Therapeutics Introduction
11.12.4 Japan Tobacco Inc. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.12.5 Japan Tobacco Inc. Recent Development
11.13 JCR Pharmaceuticals Co., Ltd.
11.13.1 JCR Pharmaceuticals Co., Ltd. Company Detail
11.13.2 JCR Pharmaceuticals Co., Ltd. Business Overview
11.13.3 JCR Pharmaceuticals Co., Ltd. Renal Anemia Therapeutics Introduction
11.13.4 JCR Pharmaceuticals Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.13.5 JCR Pharmaceuticals Co., Ltd. Recent Development
11.14 Jiangsu Hansoh Pharmaceutical Co., Ltd.
11.14.1 Jiangsu Hansoh Pharmaceutical Co., Ltd. Company Detail
11.14.2 Jiangsu Hansoh Pharmaceutical Co., Ltd. Business Overview
11.14.3 Jiangsu Hansoh Pharmaceutical Co., Ltd. Renal Anemia Therapeutics Introduction
11.14.4 Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2019-2024)
11.14.5 Jiangsu Hansoh Pharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Renal Anemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of DS-1093
Table 3. Key Players of EPO-018B
Table 4. Key Players of FG-2216
Table 5. Key Players of JTZ-951
Table 6. Key Players of MDGN-201
Table 7. Key Players of MMP-0101
Table 8. Key Players of Others
Table 9. Global Renal Anemia Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Renal Anemia Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Renal Anemia Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Renal Anemia Therapeutics Market Share by Region (2019-2024)
Table 13. Global Renal Anemia Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Renal Anemia Therapeutics Market Share by Region (2025-2030)
Table 15. Renal Anemia Therapeutics Market Trends
Table 16. Renal Anemia Therapeutics Market Drivers
Table 17. Renal Anemia Therapeutics Market Challenges
Table 18. Renal Anemia Therapeutics Market Restraints
Table 19. Global Renal Anemia Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Renal Anemia Therapeutics Market Share by Players (2019-2024)
Table 21. Global Top Renal Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Anemia Therapeutics as of 2023)
Table 22. Ranking of Global Top Renal Anemia Therapeutics Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Renal Anemia Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Renal Anemia Therapeutics Product Solution and Service
Table 26. Date of Enter into Renal Anemia Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Renal Anemia Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Renal Anemia Therapeutics Revenue Market Share by Type (2019-2024)
Table 30. Global Renal Anemia Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Renal Anemia Therapeutics Revenue Market Share by Type (2025-2030)
Table 32. Global Renal Anemia Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Renal Anemia Therapeutics Revenue Market Share by Application (2019-2024)
Table 34. Global Renal Anemia Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Renal Anemia Therapeutics Revenue Market Share by Application (2025-2030)
Table 36. North America Renal Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Renal Anemia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Renal Anemia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Renal Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Renal Anemia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Renal Anemia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Renal Anemia Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Renal Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Renal Anemia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Renal Anemia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Renal Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 51. Bayer AG Company Detail
Table 52. Bayer AG Business Overview
Table 53. Bayer AG Renal Anemia Therapeutics Product
Table 54. Bayer AG Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Bayer AG Recent Development
Table 56. BIOCAD Company Detail
Table 57. BIOCAD Business Overview
Table 58. BIOCAD Renal Anemia Therapeutics Product
Table 59. BIOCAD Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 60. BIOCAD Recent Development
Table 61. CCM Duopharma Biotech Bhd. Company Detail
Table 62. CCM Duopharma Biotech Bhd. Business Overview
Table 63. CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Product
Table 64. CCM Duopharma Biotech Bhd. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 65. CCM Duopharma Biotech Bhd. Recent Development
Table 66. Chong Kun Dang Pharmaceutical Corp. Company Detail
Table 67. Chong Kun Dang Pharmaceutical Corp. Business Overview
Table 68. Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Product
Table 69. Chong Kun Dang Pharmaceutical Corp. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 70. Chong Kun Dang Pharmaceutical Corp. Recent Development
Table 71. Daiichi Sankyo Company, Limited Company Detail
Table 72. Daiichi Sankyo Company, Limited Business Overview
Table 73. Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Product
Table 74. Daiichi Sankyo Company, Limited Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Daiichi Sankyo Company, Limited Recent Development
Table 76. Dong-A Socio Group Company Detail
Table 77. Dong-A Socio Group Business Overview
Table 78. Dong-A Socio Group Renal Anemia Therapeutics Product
Table 79. Dong-A Socio Group Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 80. Dong-A Socio Group Recent Development
Table 81. Dr. Reddy's Laboratories Limited Company Detail
Table 82. Dr. Reddy's Laboratories Limited Business Overview
Table 83. Dr. Reddy's Laboratories Limited Renal Anemia Therapeutics Product
Table 84. Dr. Reddy's Laboratories Limited Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 85. Dr. Reddy's Laboratories Limited Recent Development
Table 86. Eli Lilly and Company Company Detail
Table 87. Eli Lilly and Company Business Overview
Table 88. Eli Lilly and Company Renal Anemia Therapeutics Product
Table 89. Eli Lilly and Company Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 90. Eli Lilly and Company Recent Development
Table 91. FibroGen, Inc. Company Detail
Table 92. FibroGen, Inc. Business Overview
Table 93. FibroGen, Inc. Renal Anemia Therapeutics Product
Table 94. FibroGen, Inc. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 95. FibroGen, Inc. Recent Development
Table 96. GlaxoSmithKline Plc Company Detail
Table 97. GlaxoSmithKline Plc Business Overview
Table 98. GlaxoSmithKline Plc Renal Anemia Therapeutics Product
Table 99. GlaxoSmithKline Plc Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 100. GlaxoSmithKline Plc Recent Development
Table 101. Intas Pharmaceuticals Ltd. Company Detail
Table 102. Intas Pharmaceuticals Ltd. Business Overview
Table 103. Intas Pharmaceuticals Ltd. Renal Anemia Therapeutics Product
Table 104. Intas Pharmaceuticals Ltd. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 105. Intas Pharmaceuticals Ltd. Recent Development
Table 106. Japan Tobacco Inc. Company Detail
Table 107. Japan Tobacco Inc. Business Overview
Table 108. Japan Tobacco Inc. Renal Anemia Therapeutics Product
Table 109. Japan Tobacco Inc. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 110. Japan Tobacco Inc. Recent Development
Table 111. JCR Pharmaceuticals Co., Ltd. Company Detail
Table 112. JCR Pharmaceuticals Co., Ltd. Business Overview
Table 113. JCR Pharmaceuticals Co., Ltd. Renal Anemia Therapeutics Product
Table 114. JCR Pharmaceuticals Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 115. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 116. Jiangsu Hansoh Pharmaceutical Co., Ltd. Company Detail
Table 117. Jiangsu Hansoh Pharmaceutical Co., Ltd. Business Overview
Table 118. Jiangsu Hansoh Pharmaceutical Co., Ltd. Renal Anemia Therapeutics Product
Table 119. Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 120. Jiangsu Hansoh Pharmaceutical Co., Ltd. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Anemia Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Renal Anemia Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. DS-1093 Features
Figure 4. EPO-018B Features
Figure 5. FG-2216 Features
Figure 6. JTZ-951 Features
Figure 7. MDGN-201 Features
Figure 8. MMP-0101 Features
Figure 9. Others Features
Figure 10. Global Renal Anemia Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Renal Anemia Therapeutics Market Share by Application: 2023 VS 2030
Figure 12. Hospital Case Studies
Figure 13. Research Center Case Studies
Figure 14. Clinic Case Studies
Figure 15. Renal Anemia Therapeutics Report Years Considered
Figure 16. Global Renal Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Renal Anemia Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Renal Anemia Therapeutics Market Share by Region: 2023 VS 2030
Figure 19. Global Renal Anemia Therapeutics Market Share by Players in 2023
Figure 20. Global Top Renal Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Anemia Therapeutics as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Renal Anemia Therapeutics Revenue in 2023
Figure 22. North America Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Renal Anemia Therapeutics Market Share by Country (2019-2030)
Figure 24. United States Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Renal Anemia Therapeutics Market Share by Country (2019-2030)
Figure 28. Germany Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Renal Anemia Therapeutics Market Share by Region (2019-2030)
Figure 36. China Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Renal Anemia Therapeutics Market Share by Country (2019-2030)
Figure 44. Mexico Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Renal Anemia Therapeutics Market Share by Country (2019-2030)
Figure 48. Turkey Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Bayer AG Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 51. BIOCAD Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 52. CCM Duopharma Biotech Bhd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 53. Chong Kun Dang Pharmaceutical Corp. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 54. Daiichi Sankyo Company, Limited Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 55. Dong-A Socio Group Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 56. Dr. Reddy's Laboratories Limited Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 58. FibroGen, Inc. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 59. GlaxoSmithKline Plc Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 60. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 61. Japan Tobacco Inc. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 62. JCR Pharmaceuticals Co., Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 63. Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Renal Anemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of DS-1093
Table 3. Key Players of EPO-018B
Table 4. Key Players of FG-2216
Table 5. Key Players of JTZ-951
Table 6. Key Players of MDGN-201
Table 7. Key Players of MMP-0101
Table 8. Key Players of Others
Table 9. Global Renal Anemia Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Renal Anemia Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Renal Anemia Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Renal Anemia Therapeutics Market Share by Region (2019-2024)
Table 13. Global Renal Anemia Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Renal Anemia Therapeutics Market Share by Region (2025-2030)
Table 15. Renal Anemia Therapeutics Market Trends
Table 16. Renal Anemia Therapeutics Market Drivers
Table 17. Renal Anemia Therapeutics Market Challenges
Table 18. Renal Anemia Therapeutics Market Restraints
Table 19. Global Renal Anemia Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Renal Anemia Therapeutics Market Share by Players (2019-2024)
Table 21. Global Top Renal Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Anemia Therapeutics as of 2023)
Table 22. Ranking of Global Top Renal Anemia Therapeutics Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Renal Anemia Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Renal Anemia Therapeutics Product Solution and Service
Table 26. Date of Enter into Renal Anemia Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Renal Anemia Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Renal Anemia Therapeutics Revenue Market Share by Type (2019-2024)
Table 30. Global Renal Anemia Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Renal Anemia Therapeutics Revenue Market Share by Type (2025-2030)
Table 32. Global Renal Anemia Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Renal Anemia Therapeutics Revenue Market Share by Application (2019-2024)
Table 34. Global Renal Anemia Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Renal Anemia Therapeutics Revenue Market Share by Application (2025-2030)
Table 36. North America Renal Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Renal Anemia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Renal Anemia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Renal Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Renal Anemia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Renal Anemia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Renal Anemia Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Renal Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Renal Anemia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Renal Anemia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Renal Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 51. Bayer AG Company Detail
Table 52. Bayer AG Business Overview
Table 53. Bayer AG Renal Anemia Therapeutics Product
Table 54. Bayer AG Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Bayer AG Recent Development
Table 56. BIOCAD Company Detail
Table 57. BIOCAD Business Overview
Table 58. BIOCAD Renal Anemia Therapeutics Product
Table 59. BIOCAD Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 60. BIOCAD Recent Development
Table 61. CCM Duopharma Biotech Bhd. Company Detail
Table 62. CCM Duopharma Biotech Bhd. Business Overview
Table 63. CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Product
Table 64. CCM Duopharma Biotech Bhd. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 65. CCM Duopharma Biotech Bhd. Recent Development
Table 66. Chong Kun Dang Pharmaceutical Corp. Company Detail
Table 67. Chong Kun Dang Pharmaceutical Corp. Business Overview
Table 68. Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Product
Table 69. Chong Kun Dang Pharmaceutical Corp. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 70. Chong Kun Dang Pharmaceutical Corp. Recent Development
Table 71. Daiichi Sankyo Company, Limited Company Detail
Table 72. Daiichi Sankyo Company, Limited Business Overview
Table 73. Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Product
Table 74. Daiichi Sankyo Company, Limited Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Daiichi Sankyo Company, Limited Recent Development
Table 76. Dong-A Socio Group Company Detail
Table 77. Dong-A Socio Group Business Overview
Table 78. Dong-A Socio Group Renal Anemia Therapeutics Product
Table 79. Dong-A Socio Group Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 80. Dong-A Socio Group Recent Development
Table 81. Dr. Reddy's Laboratories Limited Company Detail
Table 82. Dr. Reddy's Laboratories Limited Business Overview
Table 83. Dr. Reddy's Laboratories Limited Renal Anemia Therapeutics Product
Table 84. Dr. Reddy's Laboratories Limited Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 85. Dr. Reddy's Laboratories Limited Recent Development
Table 86. Eli Lilly and Company Company Detail
Table 87. Eli Lilly and Company Business Overview
Table 88. Eli Lilly and Company Renal Anemia Therapeutics Product
Table 89. Eli Lilly and Company Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 90. Eli Lilly and Company Recent Development
Table 91. FibroGen, Inc. Company Detail
Table 92. FibroGen, Inc. Business Overview
Table 93. FibroGen, Inc. Renal Anemia Therapeutics Product
Table 94. FibroGen, Inc. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 95. FibroGen, Inc. Recent Development
Table 96. GlaxoSmithKline Plc Company Detail
Table 97. GlaxoSmithKline Plc Business Overview
Table 98. GlaxoSmithKline Plc Renal Anemia Therapeutics Product
Table 99. GlaxoSmithKline Plc Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 100. GlaxoSmithKline Plc Recent Development
Table 101. Intas Pharmaceuticals Ltd. Company Detail
Table 102. Intas Pharmaceuticals Ltd. Business Overview
Table 103. Intas Pharmaceuticals Ltd. Renal Anemia Therapeutics Product
Table 104. Intas Pharmaceuticals Ltd. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 105. Intas Pharmaceuticals Ltd. Recent Development
Table 106. Japan Tobacco Inc. Company Detail
Table 107. Japan Tobacco Inc. Business Overview
Table 108. Japan Tobacco Inc. Renal Anemia Therapeutics Product
Table 109. Japan Tobacco Inc. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 110. Japan Tobacco Inc. Recent Development
Table 111. JCR Pharmaceuticals Co., Ltd. Company Detail
Table 112. JCR Pharmaceuticals Co., Ltd. Business Overview
Table 113. JCR Pharmaceuticals Co., Ltd. Renal Anemia Therapeutics Product
Table 114. JCR Pharmaceuticals Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 115. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 116. Jiangsu Hansoh Pharmaceutical Co., Ltd. Company Detail
Table 117. Jiangsu Hansoh Pharmaceutical Co., Ltd. Business Overview
Table 118. Jiangsu Hansoh Pharmaceutical Co., Ltd. Renal Anemia Therapeutics Product
Table 119. Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2019-2024) & (US$ Million)
Table 120. Jiangsu Hansoh Pharmaceutical Co., Ltd. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Anemia Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Renal Anemia Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. DS-1093 Features
Figure 4. EPO-018B Features
Figure 5. FG-2216 Features
Figure 6. JTZ-951 Features
Figure 7. MDGN-201 Features
Figure 8. MMP-0101 Features
Figure 9. Others Features
Figure 10. Global Renal Anemia Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Renal Anemia Therapeutics Market Share by Application: 2023 VS 2030
Figure 12. Hospital Case Studies
Figure 13. Research Center Case Studies
Figure 14. Clinic Case Studies
Figure 15. Renal Anemia Therapeutics Report Years Considered
Figure 16. Global Renal Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Renal Anemia Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Renal Anemia Therapeutics Market Share by Region: 2023 VS 2030
Figure 19. Global Renal Anemia Therapeutics Market Share by Players in 2023
Figure 20. Global Top Renal Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Anemia Therapeutics as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Renal Anemia Therapeutics Revenue in 2023
Figure 22. North America Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Renal Anemia Therapeutics Market Share by Country (2019-2030)
Figure 24. United States Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Renal Anemia Therapeutics Market Share by Country (2019-2030)
Figure 28. Germany Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Renal Anemia Therapeutics Market Share by Region (2019-2030)
Figure 36. China Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Renal Anemia Therapeutics Market Share by Country (2019-2030)
Figure 44. Mexico Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Renal Anemia Therapeutics Market Share by Country (2019-2030)
Figure 48. Turkey Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Renal Anemia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Bayer AG Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 51. BIOCAD Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 52. CCM Duopharma Biotech Bhd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 53. Chong Kun Dang Pharmaceutical Corp. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 54. Daiichi Sankyo Company, Limited Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 55. Dong-A Socio Group Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 56. Dr. Reddy's Laboratories Limited Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 58. FibroGen, Inc. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 59. GlaxoSmithKline Plc Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 60. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 61. Japan Tobacco Inc. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 62. JCR Pharmaceuticals Co., Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 63. Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232